Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study

University of Minnesota (UMN)

Status: Completed

Conditions: Premature Birth

Treatments: Device: nasogastric tube placement pH confirmation device

Study type: Observational

Funder types: Other

Identifiers

NCT06274944

PEDS-2023-31694

Details and patient eligibility

About

This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.

Enrollment: 12 patients

Sex: All

Ages: Under 2 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients admitted to the NICU at the University of Minnesota Masonic Children's Hospital, Minneapolis, MN requiring placement of an NG/OG tube are eligible to enroll.

Exclusion criteria

• Participant deemed unsuitable for study by the treating provider. Participants who are on the following medications: proton-pump inhibitor (PPI's) or H2 blockers within one week prior to the device assessment.

Trial design

12 participants in 1 patient group

Infants

Description:

Infants admitted to the University of Minnesota Masonic Children's Hospital neonatal intensive care unit.

Treatment:

Device: nasogastric tube placement pH confirmation device